marco fornaro (@marcoforna3333) 's Twitter Profile
marco fornaro

@marcoforna3333

MD Rheumatologist and researcher at @Unibait. Passionate about myositis💪, rheumatoid arthritis🖐️, and ILD🫁. Member of @siryoung and IMACS. Football lover.

ID: 1649029580819144705

calendar_today20-04-2023 12:38:12

51 Tweet

78 Followers

74 Following

SIRyoung (@siryoung_it) 's Twitter Profile Photo

SIRyoung Rheumatology Ward Round goes on 💨 🙏 Thanks to Prof. Sinico, Vincenzo L'Imperio, MD, Dr. Conto and Dr Foti that unraveled for us the complexity of #renal involvement in systemic #vasculitides 📻 Stay tuned for our next appointement 🔜 rheumatological #emergencies.

<a href="/SIRyoung_IT/">SIRyoung</a> Rheumatology Ward Round goes on 💨

🙏 Thanks to Prof. Sinico, <a href="/VLimperioMD/">Vincenzo L'Imperio, MD</a>, Dr. Conto and Dr Foti that unraveled for us the complexity of #renal involvement in systemic #vasculitides

📻 Stay tuned for our next appointement 🔜 rheumatological #emergencies.
SIR - Società Italiana di Reumatologia (@sirreumatologia) 's Twitter Profile Photo

Che differenza c'è tra #doloreinfiammatorio e #doloremeccanico? Risponde Emanuele Bozzalla Cassione, della Fondazione IRCCS Policlinico San Matteo di Pavia. #sir #reumatologia #malattiereumatologiche youtube.com/watch?v=4-F__B…

marco fornaro (@marcoforna3333) 's Twitter Profile Photo

🔬 New data from GISEA/OEG 🇮🇹 on filgotinib in RA: Major improvements in disease activity & pain at 3 & 12 months. 📉✨ 🛡️ High retention rates, effective in monotherapy & without steroids. #Rheumatology 🔗 DOI: 10.55563/clinexprheumatol/b40rv4

Vincenzo Venerito (@vincevenerito) 's Twitter Profile Photo

🤖Anthropic Claude showed consistency with experts in scoring MDAAT for IIM patients 👩🏼‍⚕️Potential as a training tool for novice clinicians 💪LLMs may be used for patient evaluations in clinical trials tinyurl.com/y6zxxa2u Latika marco fornaro Hector Chinoy

Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ Just 2 days and already 97 participants 👍 Thank YOU, this is a great start for a very rare disease such as RELAPSING #POLYCHONDRITIS. We are going to learn sooo much about the burden of the disease and its impact on Quality of Life 🌞 Alex CRMR RESO | PACIFIC Marcela Ferrada

Kim Lauper ☮️🕊️ (@k_lauper) 's Twitter Profile Photo

EMEUNET presents #EULAR2024 session: Why do we need young national societies? (when we have already EMEUNET) with Augusta Ortolan SIRyoung Some specific educational needs in each countries and barriers

<a href="/EMEUNET/">EMEUNET</a> presents #EULAR2024 session: Why do we need young national societies? (when we have already <a href="/EMEUNET/">EMEUNET</a>) with <a href="/AugustaOrtolan/">Augusta Ortolan</a> <a href="/SIRyoung_IT/">SIRyoung</a>

Some specific educational needs in each countries and barriers
marco fornaro (@marcoforna3333) 's Twitter Profile Photo

🧬 New: Multimorbidity in idiopathic inflammatory myopathies impacts quality of life. - High comorbidity & mental health burden - 4 clinical clusters for personalized care 📷 DOI: 10.1093/rheumatology/keae520 #Myositis #Multimorbidity The CoVAD Study Uniba.it Aldo Moro Rheumatology & Rheumatology Advances in Practice

Vincenzo Venerito (@vincevenerito) 's Twitter Profile Photo

🤕IIM patients have a high burden of comorbidities, including mental health disorders. 🤖Unsupervised machine learning can identify 4 distinct clusters based on comorbidities and PROMIS scores. marco fornaro Latika The CoVAD Study 🔑academic.oup.com/rheumatology/a…

marco fornaro (@marcoforna3333) 's Twitter Profile Photo

🧬 Tapering rituximab in idiopathic inflammatory myopathies (IIM) maintains remission in 100% of patients, with reduced steroid use 💊 and no disease flares 💪. Promising for long-term management! #Rheumatology #Myositis #Rituximab Link on JBS: sciencedirect.com/science/articl…

Rohit Aggarwal (@docrota) 's Twitter Profile Photo

Hot off the Press: 1st Key Update on Myositis of the new year! Anti-Interferon (type 1) was safe and efficacious in Dermatomyositis ! Congratulations Pfizer and Dr. Fiorentino! For Lancet article. Efficacy n safety of dazukibart, an IFNβ specific antibody. sciencedirect.com/science/articl…

Dr Ai Lyn Tan (@drailyntan) 's Twitter Profile Photo

Patients with idiopathic inflammatory #myopathies have higher burden of comorbidities that influence physical & mental health ▶️Age ▶️Active disease ▶️Basic multimorbidity ▶️#MentalHealth disorders 👉🏽academic.oup.com/rheumatology/a… by marco fornaro Latika et al Rheumatology & Rheumatology Advances in Practice

Patients with idiopathic inflammatory #myopathies have higher burden of comorbidities that influence physical &amp; mental health

▶️Age
▶️Active disease
▶️Basic multimorbidity
▶️#MentalHealth disorders

👉🏽academic.oup.com/rheumatology/a…
by <a href="/marcoforna3333/">marco fornaro</a> <a href="/LatikaGupta_/">Latika</a> et al <a href="/RheumJnl/">Rheumatology & Rheumatology Advances in Practice</a>
SIRyoung (@siryoung_it) 's Twitter Profile Photo

Join us in Lazise (VR) from June 25-28, 2025, for the SIRyoung campus! Dive into research methodologies and communication skills tailored for young rheumatologists. Enhance your ability to present at conferences. Don't miss this chance to grow! #CampusSIRyoung2025 #Rheumatology

Join us in Lazise (VR) from June 25-28, 2025, for the SIRyoung campus! Dive into research methodologies and communication skills tailored for young rheumatologists. Enhance your ability to present at conferences. Don't miss this chance to grow! #CampusSIRyoung2025 #Rheumatology
Akira Yoshida (@akiyosshii1) 's Twitter Profile Photo

Our recent work from the CLASS project "Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS Project" is highlighted in Clinical Connections - 2025 - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar… ACR_Journals

Our recent work from the CLASS project "Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS Project" is highlighted in Clinical Connections - 2025 - Arthritis &amp; Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar… <a href="/ACR_Journals/">ACR_Journals</a>
SIRyoung (@siryoung_it) 's Twitter Profile Photo

Calling residents of third and fourth years and specialists under 40! The SIRyoung campus in Lazise (June 25-28, 2025) will cover essential topics like statistics, AI in medicine and scientific communication. Strengthen your skills. Secure your spot today! #CampusSIRyoung2025

Calling residents of third and fourth years and specialists under 40! The SIRyoung campus in Lazise (June 25-28, 2025) will cover essential topics like statistics, AI in medicine and scientific communication. Strengthen your skills. Secure your spot today! #CampusSIRyoung2025
marco fornaro (@marcoforna3333) 's Twitter Profile Photo

💉 Rituximab in refractory IIM (Italy) 🇮🇹 ✅ 2g/6mo: >90% improved, ↓steroids, safe (PMID: 40191951) ✅ 1g/6mo: stable remission, no flares, fewer AEs (PMID: 39326833) 🧠 Full dose → taper = smart, safe. #Rheumatology #Myositis #RTX #Autoimmunity

Vincenzo Venerito (@vincevenerito) 's Twitter Profile Photo

EMEUNET members invite you to participate in a global survey on Artificial Intelligence in Rheumatology! 🧠💻🌍 Share your insights here: lnkd.in/dNYh6iiq We're seeking input from all healthcare professionals treating rheumatic diseases (physicians, physical therapists,